Test Order

Test Order

Biodefense R&D Study
CDC-10487

Synonym(s)
Biodefense Research and Development Laboratory Study

CDC Pre-Approval Needed
David Sue
(404) 639-4027
btx6@cdc.gov
Julia Bugrysheva
(404) 639-4892
vol5@cdc.gov

Supplemental Information Required
For isolates from human specimens, prior approval is required. Consult with the lab for details.
 
Select Agent Form 2 required for submission of all confirmed Select Agents.  The Form 2 can be found at  

Supplemental Form

Performed on Specimens from
Human, Animal, and Food/Environmental/Medical Devices/Biologics

Acceptable Sample/ Specimen Type for Testing
Isolates on agar plate or slant, consult with lab for details.

Minimum Volume Required
Not Applicable

Collection, Storage, and Preservation of Specimen Prior to Shipping
Consult with lab for details

Transport Medium
Pure culture isolates (only) on sheep blood or Mueller-Hinton agar

Specimen Labeling
Test subject to CLIA regulations and requires two primary patient identifiers (e.g., patient first and last name, date of birth, unique patient identifier from time of collection, such as medical record number) on the specimen container and on the test requisition.

Shipping Instructions which Include Specimen Handling Requirements
Select agents that have been identified need form 2 approval prior to shipping.
 
CDC does not accept routine shipments on weekends or holidays. Please make sure packages arrive Monday - Friday.
 
Ship to:
<Insert CDC Point of Contact>
Centers for Disease Control and Prevention
RDSB/STATT Unit 206
1600 Clifton Road, NE
Atlanta, GA 30329
<Insert CDC Point of Contact's Telephone Number>
 
All samples must be shipped in accordance with all applicable local, state and federal regulations.

Methodology
Modified Broth Microdilution

Turnaround Time
2 Days

Interferences & Limitations
Isolates from human specimens may be tested only under Emergency Use Authorization.

Additional Information
Turnaround time can vary depending on age/purity of isolate received

CDC Points of Contact
David Sue
(404) 639-4027
btx6@cdc.gov
Julia Bugrysheva
(404) 639-4892
vol5@cdc.gov

Version
2.5